A new phase III clinical trial finds that intensity-modulated radiation therapy (IMRT) and proton beam therapy resulted in similar quality-of-life outcomes and low rates of side effects for people ...

Intensity-modulated radiotherapy is as good as proton beam therapy for treating people with head and neck cancer, according to the results of a Cancer Research UK-funded clinical trial. The TORPEdO ...

According to preliminary data from a multi-institution Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, intensity modulated proton therapy (IMPT) achieved ...

Intensity-modulated proton therapy (IMPT) matched intensity-modulated radiation therapy (IMRT) for progression-free survival in a phase III trial of oropharyngeal cancer. Patients receiving proton ...

Please provide your email address to receive an email when new articles are posted on . Men with low- or intermediate-risk prostate cancer achieved similar quality-of-life outcomes whether they ...

Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children’s Oncology Group AREN0321 Study This phase IIB trial ...

Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non–Small-Cell Lung Cancer Among younger men with prostate ...

In a phase 3 trial of patients with stage III or IV oropharyngeal cancer, intensity-modulated proton therapy (IMPT) resulted in noninferior progression-free survival and better overall survival than ...

LITTLETON, Mass.--(BUSINESS WIRE)--Mevion Medical Systems, the leading global provider of compact proton therapy solutions, and RaySearch Laboratories AB, the market leader in software solutions for ...

Atlantic Health Morristown Medical Center is on its way to becoming the first provider in New Jersey – and one of just four across the U.S. – to install a groundbreaking radiation tool for the ...

SAN FRANCISCO, September 29, 2025 — A new phase III clinical trial finds that intensity-modulated radiation therapy (IMRT) and proton beam therapy resulted in similar quality-of-life outcomes and low ...